Vnitr Lek 2005, 51(10):1087-1094

High prevalence and poor control of hypertension in offices of general practitioners

J. Widimský1,*, M. Sachová2, V. Lánská3, M. Souček4, Z. Kalita5
1 Klinika kardiologie IKEM, Praha, přednosta doc. MUDr. Jan Kautzner, CSc., FESC
2 Servier s.r.o., Praha
3 Úsek náměstka pro odbornou činnost IKEM, Praha, vedoucí MUDr. Pavel Totušek
4 II. interní klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc.
5 Neurologické oddělení Baťovy krajské nemocnice, Zlín, přednosta doc. MUDr. Zbyněk Kalita, CSc.

The work analysed the incidence of hypertension and control of hypertension in offices of 150 general practitioners. A survey was carried out using questionnaires. Each of 150 general practitioners enrolled 15 consecutively examined patients into the study. Only patients at the age of 45 years and above without age limit in the elderly age groups were enrolled. The entire population thus consisted of 2 211 individuals, of which 1 012 (45.8 %) were men and 1 195 (54.0 %) women. Hypertension was defined as blood pressure ≥ 140 and/or ≥ 90 mm Hg or as the presence of antihypertensive treatment. The study demonstrated high prevalence of hypertension in offices of general practitioners. As much as 78.4 % of the total population had visited a general practitioner for hypertension. However, the control of hypertension was not sufficiently effective. Only 18.4 % of hypertonic patients were effectively controlled, with values of BP < 140 and < 90 mm Hg. The control of hypertension in patients with ischaemic heart disease was not much better, with only 21.3 % of patients treated effectively. The control of hypertension in patients with a history of cerebral vascular event or TIA was analogous. 21.3 % of patients were treated effectively. Isolated systolic hypertension occurred in one third of hypertonic patients. The entire 83.1 % of patients with isolated systolic hypertension had systolic pressure within the range of mild isolated systolic hypertension (140-159 mm Hg). 33.2 % of hypertonic patients were treated with monotherapy, 32.2 % of patients with dual combination and only 19.1 % were treated with 3 or more antihypertensives. A total 15.5 % of hypertonic patients had never been pharmacologically treated despite higher blood pressure values. In conclusion, our data demonstrate high prevalence and poor control of hypertension in the offices of general practitioners.

Keywords: prevalence hypertension in offices of general practitioners; control of hypertension in offices of general practitioners

Received: January 11, 2005; Accepted: February 18, 2005; Published: October 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský J, Sachová M, Lánská V, Souček M, Kalita Z. High prevalence and poor control of hypertension in offices of general practitioners. Vnitr Lek. 2005;51(10):1087-1094.
Download citation

References

  1. Cífková R, Škodová Z, Lánská V et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens 2004; 18: 571-579. Go to original source... Go to PubMed...
  2. Sharma A, Wittobee AH, Kirch W et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004; 22: 479-486. Go to original source... Go to PubMed...
  3. Kalita Z, Souček M, Sachová M. Výskyt rizikových faktorů cévní mozkové příhody v populaci České republiky. Průzkum STOP CMP. Prakt Lék 2003; 83: 643-646.
  4. Horký K, Widimský J sn, Cífková R et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze (verze 2000). Cor Vasa 2001; 43(Kardio): K6-K15; Vnitř Lék 2000; 46(Suppl): 5-13.
  5. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 2003; 21: 1011-1053. Go to original source... Go to PubMed...
  6. Cífková R, Horký K, Widimský J sr et al. za Českou společnost pro hypertenzi Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2004. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2004; 50: 709-722. Go to PubMed...
  7. Woilf-Maier K, Coopoer RS, Banegas JR et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and United States. JAMA 2003; 289: 2363-2369. Go to original source... Go to PubMed...
  8. Cífková R, Škodová Z. Dlouhodobé trendy hlavních rizikových faktorů kardiovaskulárních nemocí v české populaci. Čas Lék Čes 2004; 143: 219-225.
  9. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: Results from the health survey for England 1994. J Hypertens 1998; 16: 747-752. Go to original source... Go to PubMed...
  10. Erdine S How well is hypertension controlled in Europe? European Society of Hypertension Scientific Newsletter 2000; 3.
  11. Ambrosioni E, Leonetti G, Pessina AC et al. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. J Hypertens 2000; 18: 1691-1699 Go to original source... Go to PubMed...
  12. Coca Payeras A. Evolucion del control de la hypertension arterial en Espana. Resultados del Estudio Controlpres 98. Hipertension 1998; 15: 298-308.
  13. Joffres MR, Ghandirian P, Fodor JG et al. Awareness, treatment and control of hypertension in Canada. Am J Hypertens 1997; 10: 1097-1102. Go to original source... Go to PubMed...
  14. Cífková R. Stav kontroly hypertenze v ČR a ve světě. In: Widimský J et al. Hypertenze, 2. ed. Praha: Triton 2004: 449-455.
  15. Widimský J. Kardiovaskulární skandál č. 1 - špatná léčba hypertenze v populaci. Editorial. Cor Vasa 2003; 45: 530-532.
  16. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-486. Go to original source... Go to PubMed...
  17. Chobanian A, Bakris G, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572. Go to original source... Go to PubMed...
  18. Jozífová M, Cífková R, Škodová Z et al. Porovnání léčby hypertenze a rizikového profilu hypertoniků v obecné populaci a na specializovaném pracovišti. Cor Vasa 2003; 45: 533-541.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.